ArticleJournal of affective disorders2026
Leveraging artificial intelligence to personalize treatment for eating disorders: A proof-of-concept study.
Article in Journal of affective disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Eating disorders are complex conditions with high relapse and mortality rates, and fewer than half of adults achieve clinically significant improvement with current evidence-based treatments. Personalized approaches using idiographic, data-driven monitoring have emerged to reveal individual symptom profiles, yet existing methods struggle with high-dimensional data and lack guidance for adapting care in real time. Artificial intelligence (AI) offers a complementary strategy by identifying explainable patterns in complex datasets, supporting more precise and adaptive interventions. We collected ecological momentary assessment (EMA) data from 35 participants with eating disorder diagnoses. Baseline consisted of five EMA surveys per day for 15 days, followed by two surveys per day during 12-13 weeks of treatment, yielding thousands of time-points across 14 weeks. EMA items assessed behaviors, cognitions, affect, and co-occurring symptoms on a 0-100 scale. Responses were fuzzy-encoded into graded categories to address skew and missingness. Dimensionality reduction was performed with a self-supervised Auto-Encoder, and fuzzy c-means clustering of latent representations was projected back onto EMA features to generate interpretable symptom phenotypes anchored in eating anxiety. Treatment response was quantified using Mahalanobis distance between successive embeddings, a covariance-sensitive metric highlighting atypical psychological shifts over time. The Auto-Encoder achieved RMSE = 0.25 and R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.